Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial
Titel:
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial
Auteur:
Chu, Quincy Perrone, Francesco Greillier, Laurent Tu, Wei Piccirillo, Maria Carmela Grosso, Federica Lo Russo, Giuseppe Florescu, Marie Mencoboni, Manlio Morabito, Alessandro Cecere, Fabiana Letizia Ceresoli, Giovanni Luca Dawe, David E Zucali, Paolo Andrea Pagano, Maria Goffin, John R Sanchez, Myriam Locatelli Gridelli, Cesare Zalcman, Gerard Quantin, Xavier Westeel, Virginie Gargiulo, Piera Delfanti, Sara Tu, Dongsheng Lee, Christopher W Leighl, Natasha Sederias, Joana Brown-Walker, Pamela Luo, Yiwen Lantuejoul, Sylvie Tsao, Ming-Sound Scherpereel, Arnaud Bradbury, Penelope Laurie, Scott A Seymour, Lesley